Eve Health Group Limited · ASX:EVE
Eve Health — Eve Investments — Investor Presentation (November 2017)
25 slides from Eve Health's investor presentation, Nov 15, 2017
Slide 1: Meluka Health & Omni Innovation
For personal use only Meluka Health & Omni Innovation November 2017
Slide 2: Disclaimer
The picture can't be displayed. Disclaimer For personal use only • The information contained in this presentation is not financial product advice. The presentation is for information purposes and is of a general and summary nature only. It does not constitute an offer. EVE Investments Limited (EVE)
Slide 3: Meluka Health Summary
The picture can't be displayed. Meluka Health Summary Eve has secured multiple assets across the production and sales For personal use only value chain for a unique Australian Honey Production Business. • Meluka Health has a 100% interest in Medic Honey, a Jenbrook honey production and marketing com
Slide 4: Melaleuca
The picture can't be displayed. For personal use only Melalueca • The Melaleuca tea tree is known globally for its medicinal properties, in particular it’s anti microbial, anti inflammatory power. The most common application has been through the use of its oil. • By harnessing an old growth plantati
Slide 5: Opportunity
The picture can't be displayed. Opportunity Bee populations are declining globally with For personal use only estimates suggesting a 44% decline in global bee populations caused by Bee health issues. Around a third of global food New Zealand’s natural honey exports have grown supply comes from Bee d
Slide 6: Medic Honey Target Products
The picture can't be displayed. For personal use only Medic Honey Target Products • Honey Products – Organic honey supplied by Bee Services from tea tree plantations located in the Bungawalbyn Valley Basin in northern NSW will provide the basis for the following products. – Base Meluka Honey: An act
Slide 7: Bee Hive Health
The picture can't be displayed. Bee Hive Health The disease fighting compounds Meluka Health have anecdotally identified For personal use only identified in the extract produced that Bees harvesting on flowering from the old growth melaleuca melaleuca plantations are healthier, plantation have b
Slide 8: Market Strategy
The picture can't be displayed. Market Strategy Establish methodology and extraction process for For personal use only commercial production of the Aqueous Melaleuca extract from Jendale (Old growth plantation) Establish Honey production capability to be able to fill rapid large scale demand.
Slide 9: Meluka Health Key Catalysts
The picture can't be displayed. For personal use only Meluka Health Key Catalysts Experienced Management Team Overview Bryan Easson – Founder Jenbrook Dec Production and first sales of the Base Meluka Farmer and therapeutic manufacturer with 2017 Honey Product. over 30 years experience. An organic a
Slide 10: Omni Innovation Company Overview
The picture can't be displayed. Omni Innovation Company Overview • Omni Innovation is an Australian based medical nutrition company that develops clinically validated For personal use only functional foods to improve the lives of people with common chronic diseases including type 2 diabetes, obesity
Slide 11: Key Management
The picture can't be displayed. Key Management Mr Philip Owens, Chief Executive Officer For personal use only Philip Owens has a B.Sc in Physiology and Pharmacology, as well as a grad. dip. in Psychology. Mr Owens’ strong strategic and operational skill set, and his passion for building businesses t
Slide 12: Product Development
The picture can't be displayed. Product Development Project Status For personal use only Pre meal drink for type 2 Launched, distribution partners sought / contracted diabetes Weight management Near term. Multiple formulations and portfolio approach Cognitive function Two specific target markets. Me
Slide 13: GlucoSmooth
The picture can't be displayed. For personal use only GlucoSmooth “Due to the central role of food in the management of the condition, one of the biggest challenges for many people with diabetes is maintaining the pleasure of eating. GlucoSmooth™ can help people by providing them with the flexibilit
Slide 14: GlucoSmooth: Living with diabetes
The picture can't be displayed. GlucoSmooth Living with diabetes For personal use only Like living on a bed of nails. It is all the small spikes over time that do the damage. Type 2 is recognised as the biggest People live in the real world, and managing potential disease state and burden in diabete
Slide 15: GlucoSmooth: Basis of the Pre-meal drink concept
The picture can't be displayed. GlucoSmooth Basis of the Pre-meal drink concept For personal use only The pre-load concept has been known The breakthrough was the unique ‘magic ratio’ of fibre, protein for more than 30 years and water that creates a range of physiological responses, Its application
Slide 16: GlucoSmooth: Response of blood glucose to pre-meal drink
The picture can't be displayed. For personal use only GlucoSmooth Acute Response of blood glucose to pre-meal drink Long term impact on HbA1c to pre-meal drink
Slide 17: GlucoSmooth Competitive Advantages
The picture can't be displayed. GlucoSmooth Competitive Advantages For personal use only Unique Product Offering GlucoSmooth™ is a unique and highly differentiated product with no known equivalent non-pharmaceutical substitutes available in Australia or globally. Existing functional foods for people
Slide 18: GlucoSmooth Distribution
The picture can't be displayed. For personal use only GlucoSmooth Distribution Scandinavia Canada United Kingdom USA China Taiwan India Malaysia Indonesia KEY Australia Completed Sth Africa Negotiations commenced Targeted for negotiation
Slide 19: Omni Innovation Key Catalysts
The picture can't be displayed. For personal use only Omni Innovation Key Catalysts Overview Dec First Chinese sales by partner Eagle health 2017 Q1 Launch of VLCD range into Australia, followed by international markets. 2018 Start US product sales trial and contract partners for ongoing distributio
Slide 20: Eve Investments
The picture can't be displayed. Eve Investments ASX listed technology investment company (ASX Code: EVE) For personal use only Capital Structure Ordinary Shares: 1,702,220,958 Market Cap: A$6.8 million (7 Nov) Cash: A$0.9 million (7 Nov) Debt: Nil Board of Directors & Management Key Shareholders • A
Slide 21: Eve Structure and Strategy
The picture can't be displayed. For personal use only Eve Structure and Strategy Current Eve Investments (EVE) Listed Investment Company 40% 50% Omni Innovation Meluka Health Medical Nutrition innovator Honey Production, with diabetes pre-meal drink Manufacturer, Old Growth and strong pipeline of Te
Slide 22: Appendix – NZ Natural Honey Exports
The picture can't be displayed. Appendix 1 – NZ Natural Honey Exports Natural Honey Exports in tons from NZ For personal use only 45,000 40,000 35,000 30,000 25,000 20,000 15,000 10,000 5,000 0 2013Q1 2013Q2 2013Q3 2013Q4 2014Q1 2014Q2 2014Q3 2014Q4 2015Q1 2015Q2 2015Q3 2015Q4 2016Q1 2016Q2 2016Q3 2
Slide 23: Appendix – NZ Bee Industry
The picture can't be displayed. For personal use only Appendix 2 – NZ Bee Industry
Slide 24: Appendix – NZ Honey Volume and Price
The picture can't be displayed. For personal use only Appendix 3 – NZ Honey Volume and Price
Slide 25: Appendix – Global Incidence of Diabetes
The picture can't be displayed. For personal use only Appendix 4 – Global Incidence of Diabetes Source: IDF Diabetes Atlas Seventh Edition 2015
Eve Investments — Investor Presentation (November 2017) on 6ix